HK1202155A1 - Prognostic biomarkers for the progression of primary chronic kidney disease - Google Patents
Prognostic biomarkers for the progression of primary chronic kidney diseaseInfo
- Publication number
- HK1202155A1 HK1202155A1 HK15102572.5A HK15102572A HK1202155A1 HK 1202155 A1 HK1202155 A1 HK 1202155A1 HK 15102572 A HK15102572 A HK 15102572A HK 1202155 A1 HK1202155 A1 HK 1202155A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- progression
- kidney disease
- chronic kidney
- prognostic biomarkers
- primary chronic
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20080167312 EP2180322A1 (en) | 2008-10-22 | 2008-10-22 | Prognostic biomarkers for the progression of primary chronic kidney disease |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1202155A1 true HK1202155A1 (en) | 2015-09-18 |
Family
ID=40524763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15102572.5A HK1202155A1 (en) | 2008-10-22 | 2015-03-13 | Prognostic biomarkers for the progression of primary chronic kidney disease |
Country Status (8)
Country | Link |
---|---|
US (1) | US9128107B2 (xx) |
EP (3) | EP2180322A1 (xx) |
JP (2) | JP5553835B2 (xx) |
CN (2) | CN102203621B (xx) |
DK (1) | DK2356466T3 (xx) |
ES (2) | ES2618077T3 (xx) |
HK (1) | HK1202155A1 (xx) |
WO (1) | WO2010046137A1 (xx) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7867186B2 (en) | 2002-04-08 | 2011-01-11 | Glaukos Corporation | Devices and methods for treatment of ocular disorders |
DE10316583A1 (de) * | 2003-04-10 | 2004-10-28 | B.R.A.H.M.S Aktiengesellschaft | Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung |
CN101438146B (zh) | 2006-04-04 | 2014-12-10 | 神谷来克斯公司 | 高灵敏标志物分析和分子检测的方法和组合物 |
US7838250B1 (en) | 2006-04-04 | 2010-11-23 | Singulex, Inc. | Highly sensitive system and methods for analysis of troponin |
DE102006060112A1 (de) | 2006-12-20 | 2008-06-26 | Brahms Aktiengesellschaft | Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM |
ES2663662T3 (es) | 2008-01-18 | 2018-04-16 | President And Fellows Of Harvard College | Métodos para detectar distintivos de enfermedades o afecciones en fluidos corporales |
WO2010144358A1 (en) | 2009-06-08 | 2010-12-16 | Singulex, Inc. | Highly sensitive biomarker panels |
AU2011261308C1 (en) | 2010-06-03 | 2016-02-18 | Idexx Laboratories, Inc. | Markers for renal disease |
EP3032261B1 (en) * | 2010-06-18 | 2018-05-23 | B.R.A.H.M.S GmbH | Mr-pro-amd for the prediction of incident cancer in males subject below the age of 57.9 years |
US20130266940A1 (en) | 2010-07-23 | 2013-10-10 | President And Fellows Of Harvard College | Methods of Detecting Kidney-Associated Diseases or Conditions |
SG10201505724SA (en) | 2010-07-23 | 2015-09-29 | Harvard College | Methods of detecting diseases or conditions using phagocytic cells |
US20130184178A1 (en) | 2010-07-23 | 2013-07-18 | President And Fellows Of Harvard College | Methods of Detecting Autoimmune or Immune-Related Diseases or Conditions |
SG10201505723UA (en) | 2010-07-23 | 2015-09-29 | Harvard College | Methods for detecting signatures of disease or conditions in bodily fluids |
WO2012012717A1 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting prenatal or pregnancy-related diseases or conditions |
WO2013096740A1 (en) * | 2011-12-21 | 2013-06-27 | Alere San Diego Inc. | Methods and compositions for assigning likelihood of chronic kidney disease progression |
WO2014164366A1 (en) | 2013-03-09 | 2014-10-09 | Harry Stylli | Methods of detecting cancer |
US11585814B2 (en) | 2013-03-09 | 2023-02-21 | Immunis.Ai, Inc. | Methods of detecting prostate cancer |
GB201404789D0 (en) * | 2014-03-18 | 2014-04-30 | Univ Dundee | Biomarkers |
WO2016040843A1 (en) | 2014-09-11 | 2016-03-17 | Harry Stylli | Methods of detecting prostate cancer |
CA2983542A1 (en) * | 2015-04-24 | 2016-10-27 | Sphingotec Gmbh | A method for predicting the risk of incidence of chronic kidney disease |
US10531837B1 (en) | 2015-09-25 | 2020-01-14 | Cerner Innovation, Inc. | Predicting chronic kidney disease progression |
EP3380845A1 (en) * | 2015-11-27 | 2018-10-03 | B.R.A.H.M.S GmbH | MR-proADM AS MARKER FOR THE EXTRACELLULAR VOLUME STATUS OF A SUBJECT |
US20180186543A1 (en) * | 2016-12-29 | 2018-07-05 | Dow Global Technologies Llc | Packaging Article with Three-Dimensional Loop Material |
CN107037172B (zh) * | 2017-03-29 | 2018-03-06 | 山东大学 | Cox4i1蛋白87位发生质量偏移的赖氨酸在制备重度少弱精诊断试剂中的用途 |
CN107085666B (zh) * | 2017-05-24 | 2020-07-17 | 山东大学 | 疾病风险评估与个性化健康报告生成系统及方法 |
CN111065922A (zh) * | 2017-09-13 | 2020-04-24 | B.R.A.H.M.S有限公司 | 肾上腺髓质素原作为危重病患者的肾脏替代治疗的指标 |
CN112034189B (zh) * | 2020-06-16 | 2023-03-17 | 广东省中医院(广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院) | 内皮素-1作为用于评价原发性慢性肾脏病患者无症状心血管器官损伤的标志物的应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE52916C (de) * | F. utsch in Köln-Deutz, Victoriastr. 44 | Setzmaschine | ||
NO319913B1 (no) * | 1994-12-09 | 2005-10-03 | Shionogi & Co | Fremgangsmate til sandwichimmunoassay for N-peptid |
US7713705B2 (en) * | 2002-12-24 | 2010-05-11 | Biosite, Inc. | Markers for differential diagnosis and methods of use thereof |
GB2403533A (en) * | 2003-06-30 | 2005-01-05 | Orion Corp | Atrial natriuretic peptide and brain natriuretic peptide and assays and uses thereof |
EP1628136A1 (en) * | 2004-08-19 | 2006-02-22 | B.R.A.H.M.S. Aktiengesellschaft | Method of diagnosis of disease using copeptin |
JP4976412B2 (ja) * | 2005-12-01 | 2012-07-18 | ベー・エル・アー・ハー・エム・エス・ゲーエムベーハー | エンドセリン、エンドセリンアゴニスト及びアドレノメジュリンアンタゴニストによる危篤患者の診断及び治療のための方法 |
DE102006052916A1 (de) | 2006-11-08 | 2008-05-15 | Brahms Aktiengesellschaft | Diagnose und Risikostratifizierung von Diabetes mellitus mittels MR-proADM |
-
2008
- 2008-10-22 EP EP20080167312 patent/EP2180322A1/en not_active Withdrawn
-
2009
- 2009-10-22 JP JP2011532546A patent/JP5553835B2/ja active Active
- 2009-10-22 ES ES09744969.8T patent/ES2618077T3/es active Active
- 2009-10-22 DK DK09744969.8T patent/DK2356466T3/en active
- 2009-10-22 CN CN200980142234.7A patent/CN102203621B/zh active Active
- 2009-10-22 WO PCT/EP2009/007739 patent/WO2010046137A1/en active Application Filing
- 2009-10-22 CN CN201410548781.8A patent/CN104374920B/zh active Active
- 2009-10-22 US US13/125,631 patent/US9128107B2/en active Active
- 2009-10-22 EP EP09744969.8A patent/EP2356466B1/en active Active
- 2009-10-22 ES ES14163369.3T patent/ES2587717T3/es active Active
- 2009-10-22 EP EP14163369.3A patent/EP2796879B1/en active Active
-
2013
- 2013-06-11 JP JP2013122446A patent/JP5718981B2/ja active Active
-
2015
- 2015-03-13 HK HK15102572.5A patent/HK1202155A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO2010046137A1 (en) | 2010-04-29 |
EP2356466A1 (en) | 2011-08-17 |
CN102203621A (zh) | 2011-09-28 |
US9128107B2 (en) | 2015-09-08 |
JP5718981B2 (ja) | 2015-05-13 |
JP2013178278A (ja) | 2013-09-09 |
ES2618077T3 (es) | 2017-06-20 |
CN104374920B (zh) | 2017-11-03 |
CN104374920A (zh) | 2015-02-25 |
EP2180322A1 (en) | 2010-04-28 |
JP2012506546A (ja) | 2012-03-15 |
EP2356466B1 (en) | 2016-12-21 |
JP5553835B2 (ja) | 2014-07-16 |
US20120003752A1 (en) | 2012-01-05 |
EP2796879B1 (en) | 2016-05-25 |
DK2356466T3 (en) | 2017-04-03 |
EP2796879A1 (en) | 2014-10-29 |
CN102203621B (zh) | 2016-11-23 |
ES2587717T3 (es) | 2016-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1202155A1 (en) | Prognostic biomarkers for the progression of primary chronic kidney disease | |
IL216720A (en) | Biological markers for assessing kidney disease | |
GB0719792D0 (en) | Cancer biomarkers | |
HK1154652A1 (en) | Methods of prognosis in chronic kidney disease | |
EP2373999A4 (en) | NEW BIOMARKERS | |
EP2021515A4 (en) | METHYLATED PROMOTERS AS BIOMARKERS OF COLON CANCER | |
EP2158326A4 (en) | BIOMARKERS FOR THE DIAGNOSIS OF AUTOIMMUNE DISEASES | |
EP2160478A4 (en) | Prognostic Diagnosis of Kidney Diseases | |
EP2089722A4 (en) | BIOMARKERS | |
GB2474618B (en) | Predictive biomarkers | |
ZA200907027B (en) | Biomarkers for multiple sclerosis | |
EP2265642A4 (en) | BIOMARKERS | |
IL206631A0 (en) | Biomarkers for the prediction of renal injury | |
BRPI0920069A2 (pt) | biomarcadores | |
HK1134690A1 (zh) | 子宮內膜生物標誌物 | |
EP2263086A4 (en) | BIOMARKERS | |
GB201003485D0 (en) | Kidney prognostic assay | |
GB0618127D0 (en) | Biomarker | |
EP2207685A4 (en) | DETERMINING THE CHARACTERISTICS OF A LIQUID | |
GB0818660D0 (en) | Biomarkers | |
GB0807214D0 (en) | Biomarkers | |
EP2210099A4 (en) | BIOMARKER FOR OVARIAL CARCINOMA | |
EP2265641A4 (en) | BIOMARKERS | |
GB0821912D0 (en) | Biomarkers | |
GB0818658D0 (en) | Biomarkers |